Lysine Demethylase 1 Has Demethylase-Dependent and Non-Canonical Functions in Myofibroblast Activation in Systemic Sclerosis
Cells · 2025
DOI: 10.3390/cells14060433 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Christopher W Wasson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Institute of Rheumatic and Musculoskeletal Medicine, Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, UK. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Histone Demethylases, Myofibroblasts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, UKRI, Biotechnology and Biological Sciences Research Council, Susan Cheney Scleroderma.
Abstract (Originalsprache)
Systemic sclerosis (SSc) is an autoimmune disease of unknown aetiology characterised by vasculopathy with progressive fibrosis of the skin and internal organs. Tissue fibrosis is driven by activated fibroblasts (myofibroblasts) with exacerbated contractile and secretory properties. We previously reported that the long non-coding RNA HOTAIR is a key driver of SSc fibroblast activation. HOTAIR interacts with the chromatin modifiers, the polycomb repressor complex (PRC2) and coREST complex, promoting expression of pro-fibrotic genes. In this study, we show that acute activation of dermal fibroblasts from healthy subjects or SSc patients with transforming growth factor-β and other fibrotic stimuli requires the activity of the lysine-specific demethylase 1 (LSD1) subunit of the co-REST complex. Unexpectedly, LSD1 catalytic activity plays a minor role in fibrotic gene expression in HOTAIR-overexpressing fibroblasts and in maintenance of the stable myofibroblast phenotype of SSc fibroblasts. However, silencing of LSD1 in SSc fibroblasts has a profound effect on pro-fibrotic gene expression, supporting a non-canonical scaffolding function. Our study shows for the first time an essential non-canonical role for LSD1 in pro-fibrotic gene expression in SSc; however, given that this function is insensitive to LSD1 inhibitors, the therapeutic opportunities will depend on future identification of a targetable mediator.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leeds Institute of Rheumatic and Musculoskeletal Medicine, Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, UK.
- School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK.
- Scleroderma Programme, NIHR Leeds Musculoskeletal Biomedical Research Centre, Leeds LS7 4SA, UK.
- Leeds Institute of Medical Research, Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, UK.
- Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK.
ORCID-Profile: Esther Perez Barreiro, Francesco Del Galdo, Natalia A Riobo-Del Galdo
Förderung
- Biotechnology and Biological Sciences Research Council, UKRI
- Biotechnology and Biological Sciences Research Council
- Susan Cheney Scleroderma
- Discovery Medicine North (DiMeN) Medical Research Council
- National Institute for Health Research (NIHR) Leeds Biomedical Research Centre (BRC)
Zitieren
APA
Wasson, C. W., Perez Barreiro, E., Del Galdo, F., & Riobo-Del Galdo, N. A. (2025). Lysine Demethylase 1 Has Demethylase-Dependent and Non-Canonical Functions in Myofibroblast Activation in Systemic Sclerosis. Cells. https://doi.org/10.3390/cells14060433
Vancouver
Wasson CW, Perez Barreiro E, Del Galdo F, Riobo-Del Galdo NA. Lysine Demethylase 1 Has Demethylase-Dependent and Non-Canonical Functions in Myofibroblast Activation in Systemic Sclerosis. Cells. 2025. doi:10.3390/cells14060433
BibTeX
@article{Wasson2025,
author = {Wasson, Christopher W and Perez Barreiro, Esther and Del Galdo, Francesco and Riobo-Del Galdo, Natalia A},
title = {Lysine Demethylase 1 Has Demethylase-Dependent and Non-Canonical Functions in Myofibroblast Activation in Systemic Sclerosis},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14060433}
}
EUVIMED